Alan G. Levin's Insider Trades & SAST Disclosures

Alan G. Levin's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 27,181 Automatic Stock Option Grant done . Disclosure was reported to the exchange on June 12, 2025.

Share

Note

This is a custom search result for pattern Alan G. Levin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2025	27,181	27,181	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2025	12,500	64,271 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	49,933	49,933	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	6,820	51,771 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Purchase of securities on an exchange or from another person at price $ 6.36 per share.	30 May 2024	7,861	44,951 (0%)	0%	6.4	49,996	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	39,072	39,072	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	16,745	37,090 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 8.27 per share.	31 May 2023	1,360	20,345 (0%)	0%	8.3	11,247	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 8.85 per share.	28 Feb 2023	1,271	18,985 (0%)	0%	8.8	11,248	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 13.36 per share.	30 Nov 2022	842	17,714 (0%)	0%	13.4	11,249	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 13.90 per share.	31 Aug 2022	809	16,872 (0%)	0%	13.9	11,245	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2022	30,022	30,022	-		-	Automatic Stock Option Grant
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2022	12,866	16,063 (0%)	0%		0	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 9.31 per share.	31 May 2022	1,138	3,197 (0%)	0%	9.3	10,595	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 16.61 per share.	28 Feb 2022	602	2,059 (0%)	0%	16.6	9,999	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 12.06 per share.	30 Nov 2021	829	1,457 (0%)	0%	12.1	9,998	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 15.92 per share.	31 Aug 2021	628	628 (0%)	0%	15.9	9,998	Common Stock
Biocryst Pharmaceuticals Inc.	Alan G. Levin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2021	40,000	40,000	-		-	Automatic Stock Option Grant

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades